Astrana Health (ASTH) Q2 FY26 earnings call

Astrana Health delivered a strong second quarter, driven by accelerating demand, effective medical cost management, and expanding operating leverage from its AI-native platform. The company raised its full-year adjusted EBITDA guidance while reinvesting a significant portion of its outperformance into strategic growth opportunities. Management emphasized the scalability of its payer-agnostic care model and continued progress in full-risk arrangements, alongside proactive portfolio rebalancing in Medi-Cal.